| Molecular Formula | C25H31N7O |
| Molar Mass | 445.56 |
| Density | 1.21±0.1 g/cm3(Predicted) |
| Boling Point | 676.5±65.0 °C(Predicted) |
| Solubility | DMSO: ≥ 75 mg/mL |
| pKa | 9.07±0.28(Predicted) |
| Storage Condition | -20℃ |
| Physical and Chemical Properties | Bioactive Mutated EGFR-IN-1 (Osimertinib analog) is an intermediate of mutant EGFR (L858R EGFR,Exonl9 deletion activation mutation and T790M resistance mutation) inhibitors. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.244 ml | 11.222 ml | 22.444 ml |
| 5 mM | 0.449 ml | 2.244 ml | 4.489 ml |
| 10 mM | 0.224 ml | 1.122 ml | 2.244 ml |
| 5 mM | 0.045 ml | 0.224 ml | 0.449 ml |